Insider Buying: CENTRIC HEALTH Corp (CHH) Director Purchases 25,000 Shares of Stock
CENTRIC HEALTH Corp (TSE:CHH) Director Kevin Dalton acquired 25,000 shares of the business’s stock in a transaction that occurred on Thursday, December 7th. The stock was bought at an average cost of C$0.51 per share, for a total transaction of C$12,750.00.
Shares of CENTRIC HEALTH Corp (TSE CHH) traded down C$0.01 during midday trading on Thursday, reaching C$0.50. The company’s stock had a trading volume of 374,700 shares, compared to its average volume of 375,311. CENTRIC HEALTH Corp has a 52 week low of C$0.50 and a 52 week high of C$0.91.
A number of research analysts recently weighed in on CHH shares. National Bank Financial cut their price objective on CENTRIC HEALTH from C$0.80 to C$0.75 in a research note on Thursday, November 16th. Canaccord Genuity cut their price objective on CENTRIC HEALTH from C$1.20 to C$1.10 in a research note on Thursday, November 16th.
Centric Health Corp is a Canada-based company primarily engaged in the drug retail sector. The Company’s activities are divided into two business segments: Specialty Pharmacy, as well as Surgical and Medical Centers. The Specialty Pharmacy division focuses on the drug retail and wholesale through pharmacies and fulfillment locations, as well as it offers additional drug-relates services, such as compounding and dispensing medications, advisory, addiction management and specialty services for long-term care and retirement facilities.
Receive News & Ratings for CENTRIC HEALTH Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CENTRIC HEALTH Corp and related companies with MarketBeat.com's FREE daily email newsletter.